Introduction {#Sec1}
============

Animal models are commonly used in tendon disorder research. They have the advantages of incorporating invasive evaluation techniques, and the possibility for detailed tissue examination and analysis of biochemical substances. These models may be useful in reproducing some aspects of human tendon disorders because in animal models it is easier to control single factors.

In experimental studies on animal tendons, partial or total surgical tenotomy is the most commonly used method for inducing injury \[[@CR1]--[@CR8]\]. Another, nonsurgical, method of injury induction has been introduced in a few studies of tendons in small rodents \[[@CR9]--[@CR11]\]. In this model, an external blunt trauma is inflicted by a mini guillotine where a block falls down from a fixed height and crushes the tendon. After such an injury in a mini guillotine, significant histological changes have been found when compared to healthy tendons \[[@CR9]--[@CR11]\]. However, other relevant outcome measures such as edema and the tendon's ability to withstand load, have not yet been investigated.

The primary purpose of tendons is to transmit tensile load from muscles to bone insertions. Their biomechanical properties can be measured by their ultimate tensile strength (UTS). UTS is an outcome measure of a the tendon\'s ability to tolerate tensile load and elongation \[[@CR12]\]. In two studies on rat tendons where UTS was used as an outcome measure, healthy rat Achilles tendon had UTS values of 42.5 ± 5.5 N (mean ± SD) \[[@CR13]\] and 48 ± 11.0 N \[[@CR14]\].

Low-level laser therapy (LLLT) is considered to act in a biomodulatory manner through light absorption by photoreceptors, which stimulates cells and modulates inflammatory processes \[[@CR15]--[@CR19]\]. Studies performed in a variety of different pathological conditions including injured animal tendons are frequent in the LLLT literature. In most of these LLLT studies, tendons were treated daily for 3 to 21 days \[[@CR1]--[@CR5], [@CR9], [@CR11]\]. Observed histopathological changes in tendons receiving LLLT include increased collagen production \[[@CR1]\], improved collagen bundle organization \[[@CR2]--[@CR4], [@CR11]\], and an increased number of small blood vessels \[[@CR9]\]. Some studies have investigated the effect of LLLT within the first 24 h after an acute inflammation. After induction of inflammation followed by three or four LLLT sessions, tissue receiving LLLT exhibited reduced concentrations of inflammatory markers and cells compared to no-treatment controls \[[@CR20], [@CR21]\].

In the clinical setting tendon disorders are common. Tendon loading seems to be a risk factor for developing tendon disorders, particularly in the upper extremities among manual workers \[[@CR22]\] and in the lower extremities among athletes \[[@CR23]\]. Acute tendinitis may occur after unfamiliar repetitive movement, friction and pressure during tendon loading, and is often seen in the Achilles tendons of military recruits after long marches \[[@CR24]\]. Chronic tendinopathies have a more complex etiology and manifestation, and development of chronic tendinopathies may be gradual and less clearly associated with tendon loading episodes. Age seems to be of importance, and partial or complete tendon ruptures are strongly correlated with age \[[@CR25]\]. Developing experimental animal models which accurately mimic the clinical situation in chronic tendinopathies is a challenge, and the ultimate experimental model has yet to be found \[[@CR26]\]. Soslowsky et al. \[[@CR27]\] developed a rat model of repetitive loading of the supraspinatus in treadmill running, but some aspects including genetics and the influence of pre-experimental structural tendon defects, have not been catered for. Another, as yet unused, possibility for mimicking tendinopathies is to repeat infliction of injury by blunt trauma.

During the last two decades, ultrasonographic imaging (US) has become a popular diagnostic tool for assessment of musculoskeletal disorders \[[@CR28]\]. US is reported to have high accuracy in diagnosing disorders in superficial human tendons \[[@CR28]--[@CR30]\].

The aim of this study was to investigate the effects of LLLT administered 30 min after an Achilles tendon injury inflicted by a mini guillotine. The outcome was measured as tendon edema on US and tendon tensile strength.

Method {#Sec2}
======

Animals {#Sec3}
-------

The study animals comprised 16 male rats (Sprague Dawley SD M; Taconic Europe, Denmark) weighing 250--300 g, which were divided in two groups. The rats were housed four and four in individually ventilated cages under a light cycle of 12 hours light/12 hours dark, in an atmosphere of humidity 55% and a temperature range of 20--22°C, and with water and food ad libitum.

Instruments {#Sec4}
-----------

**Mini guillotine** The mini guillotine comprised a block weight of 200 g with a blunt edge 2 mm wide that was dropped from 20 cm guided by supports (Fig. [1](#Fig1){ref-type="fig"}). Fig. 1**a** Mini guillotine with rat positioned for Achilles injury. **b** (*insert*) Close-up of the tendon crush location

**Laser** The laser emitted radiation at a wavelength 904 nm (Irradia, Sweden) and was operated in pulsed mode. The peak power was 20 W, the pulse width 200 ns and the frequency 700 Hz. The mean output power was 60 mW, the spot size 0.38 cm^2^ and the power density 60 mW/0.38 cm^2^ (= 0.158 W/cm^2^). Two identical single diode laser probes were use, one with active laser and the other an inactive/placebo probe. Irradiation was applied for 50 s. Thus 3 J was delivered from the active laser.

**Ultrasonography** The US instrument was a GE Logiq e (GE Healthcare, Minneapolis, MN) with a 12 MHz linear probe.

**Material test system** A servohydraulic testing machine (MTS 810; MTS, Minneapolis, MN) equipped with a calibrated load cell of 500 N and a position transducer of 100 mm was used. The deformation rate was 0.25 mm/s. The load and deformation data were sampled continuously during the test.

Experimental procedure {#Sec5}
----------------------

One investigator (J.M.B.) labeled one laser probe with blue tape and the other with yellow tape. The code for active and placebo probes were not disclosed until the statistical analysis was done. The laser probe output was then measured to determine which probe had been the active one. The main outcome measures were tendon thickness (including the peritendon) as measured on ultrasonographic images and UTS. The study was approved by the local animal laboratory committee at the University of Bergen (application no. 20102676).

The experimental procedure (Fig. [2](#Fig2){ref-type="fig"}) was carried out in six steps: The animal was anesthetized with isoflurane (Isoba) using an Isotec vaporizer. Under anesthesia, the animal's right ankle was positioned in full dorsal flexion in the mini guillotine such that the edge of the block hit just proximal to the insertion on the calcaneus (Fig. [1](#Fig1){ref-type="fig"}). This procedure was carried out by J.J. After injury, the animal's tail was marked to distinguish it from others in the cage, and was put back into the cage. All animals in each group were subjected to this procedure.Half an hour after injury, the animal was again anesthetized and the injured area was treated for 50 s with either active (3 J) or placebo LLLT delivered to one single point (performed by J.J.). A new mark was put on the tail. This treatment procedure was repeated in all eight animals in each group.The next day, 15 h after the first injury, the same area of the right Achilles tendon was again injured using the guillotine according to the procedure in step 1 and half an hour after later the area was treated for 50 s with LLLT according to the procedure in step 2. This procedure was performed by J.J.On day three, 23 h after the second injury, US was performed bilaterally on the right and left Achilles tendon (carried out by S.H.). The imaging depth was set to 2 cm, with three focus areas around the first centimeter (Fig. [3](#Fig3){ref-type="fig"}). The animal was anesthetized and the Achilles tendon area was scanned in both the longitudinal and transverse planes, two images in both planes. The longitudinal plane was scanned with the whole length of the Achilles tendon in the image. Tendon thickness (including peritendon) in the longitudinal plane images was measured from the os calcaneus up to the deeper layer of the skin (Fig. [3](#Fig3){ref-type="fig"}). When scanning the Achilles tendon and the adjacent structures in the transverse plane the probe was moved distally from the knee until it met the os Calcaneus, and images were acquired in this position. The thickness in the transverse plane was measured as the vertical distance within the anterior and posterior border of the peritendon. In the statistical analyses the averages of the measurements from two US images were used. Each animal's tail was marked after the US scan was complete.The animals were anesthetized 2 h later and given 0.4 ml intraperitoneal anesthetic (Mebumal 50 mg/ml; 1 ml contains 54.9 mg pentobarbital sodium, 400 g propylene glycol, 150 mg strong alcohol and distilled water to 1 ml). The animals were killed by injection of 1 ml saturated potassium chloride solution to cause cardiac arrest. The skin overlying the right gastrocnemius muscle was released from the calcaneus to the proximal part of the triceps surae muscle. The Achilles tendon was then released with scissors, and the muscle fibers were removed from the tendons with a scalpel. Water containing 9% sodium chloride was sprayed over the tendon. The tendon was put into a small plastic bag, labeled and stored in a refrigerator at 4°C. The same procedure was used for the left Achilles, and on all animals. This was carried out by J.J.The tendons were subjected to UTS testing 3 h after release. The proximal end of the Achilles tendon was sprinkled with 250 μm alumina powder before it was gripped in a clamp to prevent sliding. A special conically designed grip for the distal end of Achilles tendon was used. In this grip the os calcaneus was used as a plug to obtain the optimal tendon grip \[[@CR31], [@CR32]\] (Fig. [4](#Fig4){ref-type="fig"}). The maximal load for each tendon at failure was recorded. The procedure was performed by OJ.L. and N.R.G.Fig. 2The experiment time scheduleFig. 3Longitudinal US images with tendon thickness measurements. Active LLLT group 2) left and right Achilles tendon (rat 5), 0.70 mm and 0.93 mm, respectivelyFig. 4A rat Achilles tendon at the moment of rupture during UTS testing

Statistical analysis {#Sec7}
--------------------

Differences between injured right Achilles and healthy left Achilles tendons were analyzed using a paired *t*-test, and differences between groups were analyzed using the *t*-test in SPSS (version 18) from Microsoft.

Results {#Sec9}
=======

The thickness of the injured right and the healthy left Achilles tendons in the longitudinal US images were significantly different (*p* \< 0.05) in the active LLLT group (Table [1](#Tab1){ref-type="table"}), but were not significantly different in the placebo LLLT group (*p* = 0.35; Table [1](#Tab1){ref-type="table"}). The mean thickness of the injured right Achilles tendon was 0.93 ± 0.03 mm in the active LLLT group and 0.73 ± 0.07 mm in the placebo LLLT group, and the mean thickness of the healthy left Achilles tendon (including the peritendon) was 0.69 ± 0.07 mm and 0.70 ± 0.10 mm, respectively. Table 1Thickness (means ± SD) of the injured and healthy Achilles tendons and mean differences in thickness as measured by US and UTS (*n* = 8)GroupViewTendon thickness (mm)95% CI*p* valueRight (injured)Left (healthy)Difference (injured − healthy)USPlacebo LLLTLongitudinal0.73 ± 0.030.70 ± 0.100.03 ± 0.09−0.04 to 0.110.35Transverse0.63 ± 0.140.57 ± 0.070.07 ± 0.12−0.03 to 0.170.16Active LLLTLongitudinal0.93 ± 0.030.69 ± 0.070.24 ± 0.070.18 to 0.300.00\*Transverse0.70 ± 0.100.51 ± 0.070.19 ± 0.100.10 to 0.270.00\*UTSPlacebo LLLT57.64 ± 7.8059.66 ± 11.86−2.02 ± 15.09−14.64 to 10.600.72Active LLLT51.11 ± 9.7753.94 ± 9.80−2.83 ± 10.76−11.82 to 6.160.48\**p* ≤ 0.05.

In the transverse US images the difference between the injured right and the healthy left Achilles tendon was significant (*p* \< 0.05) in the active LLLT group (Table [1](#Tab1){ref-type="table"}), but was not significant the placebo LLLT group (*p* = 0.16; Table [1](#Tab1){ref-type="table"}). The mean transverse thickness of the injured right Achilles tendon was 0.70 ± 0.10 mm in the active LLLT group and 0.63 ± 0.14 mm in the placebo LLLT group. The mean thickness of the healthy left Achilles tendon in the two groups was 0.51 ± 0.07 mm and 0.57 ± 0.07 mm, respectively.

There were no significant differences in UTS between the injured right and healthy left Achilles tendon in the active LLLT group or in the placebo LLLT group (Table [1](#Tab1){ref-type="table"}). The mean UTS in the injured right Achilles tendon was 51.11 ± 9.77 N in the active LLLT group and 57.64 ± 7.80 N in the placebo LLLT group. The mean UTS in the healthy left Achilles tendon was 53.94 ± 9.80 N in the active LLLT group and 59.66 ± 11.86 N in the placebo LLLT group.

Discussion {#Sec10}
==========

Biomechanical test methods are commonly used in the evaluation of surgically induced tendon injuries \[[@CR31]--[@CR33]\]. The UTS values are fairly low during the first 2 weeks after tenotomy and previous studies have avoided UTS testing in models where tendons are not seriously weakened by sharp trauma. Measuring UTS after tendon injury induced by a mini guillotine has to our knowledge not previously been reported in the literature. After a standardized injury in a mini guillotine, rat tendons show histopathological changes \[[@CR9]--[@CR11]\]. However, we found no differences in the biomechanical properties as revealed by UTS between injured and healthy rat Achilles tendons 1--2 days after injury. Similar UTS values have been found in rat Achilles tendons subjected to carrageenan injection \[[@CR34]\].

A major technical challenge in UTS testing of healthy rat Achilles tendons is to obtain a reliable, nonsliding grip of the proximal end of the tendon. We have found only two studies investigating UTS of healthy rat Achilles tendons, possibly because grip slippage before the tendon ruptures. In this study we succeeded in developing a grip with a combination of rolling the tendon around conical anchors, and the application of alumina powder to enhance friction. Thus, grip-induced rupture was avoided, and most tendons ruptured a few millimeters from the distal grip with forces up to 75.2 N.

The standard deviation of the UTS of healthy rat Achilles tendons is  ±10 N (present results, and references \[[@CR14]\] and \[[@CR34]\]) and the difference between healthy and injured tendons is typically 2--3 N. Thus, in future studies with the mini guillotine and UTS, the injury procedure will have to be refined in order to weaken the tendon sufficiently to obtain significant decreases in UTS values after injury.

An irradiation dose of 3 J is commonly used in clinical practice in human inflammatory conditions and was taken from the dose recommendations of the World Association for Laser Therapy (WALT) \[[@CR35]\]. In retrospect, this may have been too high for rat Achilles tendon pathology. Optimal irradiation doses from 904-nm lasers in rat muscles seem to be closer to 1 J. In a new study with LLLT, doses of 0.1, 0.3, 1.0 and 3.0 J were used to prevent skeletal muscle fatigue and possible muscle damage. All irradiated groups except the group irradiated at a dose of 3.0 J had significantly lower post-exercise creatine kinase activity than the control group immediately after the contraction tests \[[@CR36]\]. If these doses translate to rat Achilles tendons, it could explain the nonsignificant differences, but not the increased edema observed in the active LLLT group.

In the current study there was an interval of 15 h between the two LLLT irradiations. There are very few studies in which there was an interval of less than 24 h between irradiations. Thus, we cannot rule out the possibility that an interval of 15 h was too short and resulted in negative effects of LLLT. This is clearly an area where more research is needed. A more likely explanation for the increased edema in the active LLLT group could be an indirect consequence of symptomatic pain reduction from LLLT leading to increased activity causing more edema \[[@CR37], [@CR38]\]. Reduced pain sensation from the injured tissue could promote physical activity, and this may result in a temporary increase in edema at the site of injury during the 23 h between the LLLT irradiation session and the US examination \[[@CR39]\].

The timing of LLLT irradiation in the acute phase of inflammation is seldom discussed in the literature, but it can be crucial for achieving positive effects. In some animal studies, LLLT treatment has been found to reduce edema, and is typically been measured 4 hours after injury \[[@CR40]--[@CR42]\]. Thus, we did not expect to find an increase in edema after a single LLLT treatment 30 min after injury. We speculate that the unexpected differences between the results may be explained by differences in study design. Scrutiny of the design of other similar LLLT studies showed that LLLT has mainly been administered later than 30 min after injury \[[@CR42]\] and/or that the treatment procedure included more than a single LLLT session \[[@CR2], [@CR3], [@CR9], [@CR21], [@CR40], [@CR41]\].

It is known that LLLT energy acts on biological processes \[[@CR43]\]. We therefore considered the cascade of responses in the acute phase of inflammation, and in particular which processes are dominant in the first half hour. The immediate response in the innate immunity after an injury is activation of signal transduction mechanisms. Immediate genes activated within the first half hour of inflammation are mainly transcription factors \[[@CR44], [@CR45]\]. Among these expressed cytokine gene is mitogen-activated protein kinase (MAPK) \[[@CR46]\]. Three well-characterized subfamilies of MAPK are stress-activated protein kinases/c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38) and extracellular regulated protein kinases (ERK) \[[@CR44], [@CR47], [@CR48]\]. Peak times for kinases have been established for JNK, p38 and ERK in tendon cells, smooth muscle cells, endothelial cells and cardiac fibroblasts. JNK, p38 and ERK increase rapidly, and they reach a maximum within 10 to 30 min \[[@CR49]--[@CR52]\]. The impact of JNK, p38 and ERK on edema has been investigated in rodent paw models and brain injury models using inhibitors for JNK, p38 and ERK, respectively. Tested selectively, all these inhibitors reduce the development of edema, and consequently JNK, p38 and ERK may increase edema development \[[@CR53]--[@CR56]\].

The effect from LLLT (632.8 nm, 4.5 mW) on JNK, p38 and ERK has been investigated in skeletal muscle cells. LLLT does not increase JNK and p38 activation or protein expression, but LLLT induces protein translation through ERK pathways \[[@CR57], [@CR58]\]. Perhaps the unexpected increase in edema development in the LLLT group in our study can be explained through a stimulation of the ERK pathway. But this is speculative as we did not measure any of the outcomes needed to confirm or refute this theory.

We also explored studies with LLLT irradiation within the first half hour after injury (injection or surgery) with regard to edema development. In a previous study by members of our research group \[[@CR40]\], different timing protocols for LLLT (650 nm) were used. Carrageenan was injected into rat paws and edema was measured 1 to 4 h later. The main conclusion was that LLLT has an antiinflammatory effect in most cases, but one group treated with LLLT had developed increased edema 10 min after injection compared to controls.

Some clinical studies in dentistry have evaluated the effect of LLLT on edema development immediately after surgery \[[@CR59]--[@CR64]\]. The timing of LLLT administration was not explicitly reported, but in two studies report the duration of surgery was 19 min \[[@CR63], [@CR64]\]. In one study, LLLT given immediately after surgery was found to have increased edema at 3 days, but not at 7 days \[[@CR62]\]. Two studies with adequate doses found reduced edema \[[@CR63], [@CR64]\]. In three studies LLLT doses did not meet the WALT dose recommendations for LLLT. One study used a scanning mode for application of the laser beam \[[@CR61]\], and the other two used doses that were too low (\<1 J) \[[@CR59], [@CR60]\].

Even though the results regarding edema development in studies in which LLLT was used within the first half hour after injury are arbitrary, it is not unlikely that LLLT irradiation within the first half hour after an injury will temporarily increase edema. This finding has important clinical implications, as it has been an open question as to when is the earliest time-point for effective LLLT administration. Interestingly, in some studies LLLT has been administered before muscle damage or the onset of inflammatory process with good results on other outcome measures \[[@CR36], [@CR65]\]. This indicates that the negative effect on edema development is restricted to inflamed tissue and the first half hour after the onset of inflammation.

Our decision to use the mini guillotine model was an attempt to mimic a tendon disorder with inflammatory components. Signs of inflammation are present in acute and mild tendinopathies \[[@CR66], [@CR67]\]. In previous studies using the mini guillotine injury method in rodents, the injured tendons have shown inflammatory reactions \[[@CR9]--[@CR11]\]. The significant increase in thickness of the injured tendons supports the suitability of the mini guillotine model for causing Achilles tendinopathy in the rat. The mini guillotine model has the advantage of being easier to use than overuse models such as the treadmill running model of Soslowsky et al. \[[@CR68]\]. None of these models involves penetration of the skin and therefore they avoid the risk of infection during the injury procedure. The surgical procedure of tenotomy does introduce a risk for infection, and it may also be questioned as to how relevant this model for investigation of tendinopathies.

The use of animal models in research on human tendinopathies has its limitations. There are obvious anatomical differences between bipeds and quadrupeds. This affects the validity of using animal models to study tendinopathies, and limits extrapolation of the findings in animal studies to human tendinopathies. Whether effective laser parameters in small rodent models can be extrapolated to humans remains uncertain and additional clinical studies in humans to verify or repute the findings are called for.

Conclusion {#Sec11}
==========

Laser irradiation at 0.158 W/cm^2^ for 50 s (3 J) administered within the first half hour after two blunt trauma injuries15 h apart appeared to increase edema in the rat Achilles tendon measured at 23 h after LLLT.

The UTS of the rat Achilles tendon was not decreased significantly after two blunt traumas inflicted by a mini guillotine. This experimental model appears useful for investigating the optimal timing and effect of therapies in acute tendon injuries. In this model, edema can be reliably measured by US, and tendon UTS can be reliably tested in both healthy and weakened rat Achilles tendons. There is a need to further refine the experimental procedure to achieve a weakening of the rat Achilles tendon. Further studies with this model should include variations in the intervals between traumas, the timing of treatment, the number of LLLT sessions and the power densities.

**Open Access** This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
